Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionKimelman & Baird, LLC
Latest Disclosed Ownership14,240 shares
Latest Disclosed Value $ 5,010,344
Kimelman & Baird, LLC ownership in AMGN / Amgen Inc.

On May 13, 2026 - Kimelman & Baird, LLC filed a 13F-HR form disclosing ownership of 14,240 shares of Amgen Inc. (CH:AMGN) valued at $5,010,344 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 14,240 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AMGEN COM 031162100 14,240 0 0.00 5,010 7.51 0.4123
2026-02-06 2025-12-31 13F AMGEN COM 031162100 14,240 0 0.00 4,661 15.98 0.3581
2025-11-25 2025-09-30 13F AMGEN COM 031162100 14,240 -550 -3.72 4,019 -2.69 0.3138
2025-08-12 2025-06-30 13F AMGEN COM 031162100 14,790 -10 -0.07 4,130 -10.43 0.3362
2025-05-13 2025-03-31 13F AMGEN COM 031162100 14,800 0 0.00 4,611 19.52 0.3917
2025-02-10 2024-12-31 13F AMGEN COM 031162100 14,800 -1,500 -9.20 3,857 -26.56 0.3066
2024-11-15 2024-09-30 13F AMGEN COM 031162100 16,300 -100 -0.61 5,252 2.50 0.4190
2024-08-19 2024-06-30 13F AMGEN COM 031162100 16,400 12,800 355.56 5,124 484.26 0.4226
2021-08-17 2021-06-30 13F Amgen cs 031162100 3,600 0 0.00 877 25.82 0.0782
2019-12-10 2019-09-30 13F Amgen cs 031162100 3,600 0 0.00 697 5.13 0.0966
2019-11-22 2019-06-30 13F Amgen cs 031162100 3,600 0 0.00 663 -3.07 0.0922
2019-07-02 2019-03-31 13F Amgen cs 031162100 3,600 0 0.00 684 -2.43 0.0984
2019-02-15 2018-12-31 13F Amgen cs 031162100 3,600 0 0.00 701 -6.03 0.1091
2019-01-30 2018-09-30 13F Amgen cs 031162100 3,600 0 0.00 746 12.18 0.0940
2019-01-24 2018-06-30 13F Amgen cs 031162100 3,600 0 0.00 665 6.23 0.0873
2018-03-06 2017-12-31 13F Amgen cs 031162100 3,600 0 0.00 626 -6.71 0.0890
2018-01-02 2017-09-30 13F Amgen cs 031162100 3,600 0 0.00 671 8.23 0.1000
2017-08-22 2017-06-30 13F Amgen COM 031162100 3,600 0 0.00 620 4.91 0.0940
2017-05-17 2017-03-31 13F Amgen COM 031162100 3,600 0 0.00 591 12.36 0.0900
2017-04-10 2016-12-31 13F Amgen COM 031162100 3,600 0 0.00 526 -12.48 0.0882
2016-12-13 2016-09-30 13F Amgen COM 031162100 3,600 0 0.00 601 9.67 0.1057
2016-08-16 2016-06-30 13F Amgen COM 031162100 3,600 0 0.00 548 1.48 0.1002
2016-05-13 2016-03-31 13F Amgen COM 031162100 3,600 0 0.00 540 -7.53 0.1009
2016-02-12 2015-12-31 13F Amgen COM 031162100 3,600 0 0.00 584 5.61 0.1098
2015-08-12 2015-06-30 13F Amgen cs 031162100 3,600 600 20.00 553 15.21 0.0943
2015-05-12 2015-03-31 13F Amgen cs 031162100 3,000 0 0.00 480 0.42 0.0875
2015-02-12 2014-12-31 13F Amgen cs 031162100 3,000 0 0.00 478 13.54 0.0861
2014-11-13 2014-09-30 13F Amgen COM 031162100 3,000 0 0.00 421 18.59 0.0796
2014-08-14 2014-06-30 13F Amgen cs 031162100 3,000 -150 -4.76 355 -8.74 0.0625
2014-05-20 2014-03-31 13F Amgen cs 031162100 3,150 0 0.00 389 8.36 0.0725
2014-02-13 2013-12-31 13F Amgen COM 031162100 3,150 0 0.00 359 1.70 0.0687
2013-11-13 2013-09-30 13F Amgen COM 031162100 3,150 0 0.00 353 13.50 0.0705
2013-08-07 2013-06-30 13F Amgen COM 031162100 3,150 3,150 311 0.0655
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.